Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» IPOs
IPOs
This week's wave of biotech IPO players bumps up offerings and targets bigger harvests of cash
Endpoints
Thu, 07/23/20 - 11:16 am
IPOs
biotech
Inozyme Pharma
Annexon
AlloVir
Nurix Therapeutics
Inozyme plans $75m IPO as it heads for clinic with rare bone diseases drug
Pharmaforum
Mon, 07/20/20 - 11:51 pm
IPOs
Inozyme Pharma
rare bone diseases
China's CRO powerhouse Tigermed to seek $1B IPO in Hong Kong — report
Endpoints
Mon, 07/20/20 - 10:22 am
China
Hong Kong
Hangzhou Tigermed
CRO
biotech
IPOs
Three more biotechs tumble onto Wall Street today, raising $475M as the IPO party rocks on
Endpoints
Fri, 07/17/20 - 10:52 am
IPOs
ALX Oncology
Berkeley Lights
Pandion Therapeutics
NASDAQ
Relay Therapeutics prices IPO at $400M
MedCity News
Thu, 07/16/20 - 10:47 am
Relay Therapeutics
IPOs
drug discovery
3 Biotech IPOs Together Rake In Over a Half Billion to Advance Treatments
Xconomy
Mon, 07/13/20 - 11:33 pm
biotech
IPOs
Nkarta Therapeutics
Poseida Therapeutics
Inventiva
Another four biotechs scratch out the first number and ask for more as IPO boom continues
Endpoints
Fri, 07/10/20 - 11:00 am
IPOs
biotech
Relay Therapeutics
Nkarta Therapeutics
Poseida Therapeutics
Inventiva
Ophthalmic drugs, cancer cell therapies attract $340M+ on two HKEX biotech debuts
Endpoints
Fri, 07/10/20 - 10:52 am
biotech
IPOs
HKEX
Hong Kong
Ocumension Therapeutics
Immunotech Biopharm
What pandemic? Biotech floats break records
EP Vantage
Wed, 07/8/20 - 10:37 am
biotech
IPOs
ADC Therapeutics
Akouos
Applied Molecular Transport
Avidity Biosciences
Ayala Pharmaceuticals
Forma Therapeutics
Fusion Pharmaceuticals
Generation Bio
Hyloris Pharmaceuticals
Lantern Pharma
ORIC Pharmaceuticals
Pliant Therapeutics
PolyPid
Repare Therapeutics
Royalty Pharma
SutroVax
FDA lifts partial hold on ADC, clearing way for a 2021 readout and two potential near-term approvals
Endpoints
Mon, 07/6/20 - 11:01 am
ADC Therapeutics
IPOs
FDA
Cami
Hodgkin's lymphoma
Newly merged Mereo BioPharma looks to OncoMed for R&D hires
Fierce Biotech
Tue, 06/30/20 - 10:35 am
Mereo BioPharma
IPOs
OncoMed
R&D
The biotech IPO boom is becoming ‘historic’ as four more throw their hats in
Endpoints
Mon, 06/29/20 - 10:34 am
IPOs
biotech
Berkeley Lights
ALX Oncology
Pandion Therapeutics
Kiromic Biopharma
Relay Lays $200M IPO Plan to Fund Tests of Protein Motion Cancer Drugs
Xconomy
Thu, 06/25/20 - 10:45 am
Relay Therapeutics
IPOs
protein motion
cancer
After filing for IPO, ArcherDX agrees to $1.4B buyout by Invitae
MedCity News
Tue, 06/23/20 - 11:35 pm
ArcherDX
M&A
IPOs
cancer
Invitae
Meet the Pharma Company That Just Had a Bigger IPO Than Moderna's
Motley Fool
Tue, 06/23/20 - 11:07 am
IPOs
Moderna Therapeutics
Royalty Pharma
Poseida Therapeutics guns again for IPO
Fierce Biotech
Mon, 06/22/20 - 10:32 am
Poseida Therapeutics
CAR-T
IPOs
The biotech IPOs keep coming at chart-topping levels — with no slowdown in sight
Endpoints
Fri, 06/19/20 - 11:27 am
biotech
IPOs
Repare Therapeutics
Forma Therapeutics
Avidity Biosciences
Vaxcyte
SK Biopharmaceuticals
Generation Bio
Royalty Pharma
4DMT to Use $75 Million Series C to Advance Three Key Pipeline Products
BioSpace
Tue, 06/16/20 - 06:57 pm
4D Molecular Therapeutics
IPOs
gene therapy
Royalty Pharma scores $2.2B IPO — the biggest of the year
Endpoints
Tue, 06/16/20 - 10:44 am
Royalty Pharma
IPOs
NASDAQ
SK Biopharmaceuticals emerges from pandemic delays with pitch for $822M IPO
Endpoints
Mon, 06/15/20 - 11:01 am
SK Biopharmaceuticals
South Korea
IPOs
Pages
« first
‹ previous
…
11
12
13
14
15
16
17
18
19
…
next ›
last »